Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsAspirus Arise Part D Transition Coverage Policy Up…
    Ask Trek AI about this page
    CurrentAspirus ArisePolicy N/A

    Part D Prescription Drug Transition Policy

    Customize your policy alerts

    Sign up for all Aspirus Arise policy alerts

    Know when Aspirus Arise releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Temporary supply and transition procedures for Part D prescription drugs for Aspirus Health Plan Medicare members during enrollment changes, level-of-care changes, or pending coverage determinations; affects new and current members in retail and long-term care settings.

    Policy Summary
    PayerAspirus Arise
    PolicyPart D Prescription Drug Transition Policy
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionProvide a temporary supply (retail 30 days; LTC 31 days) while prior authorization, step therapy, or exception is pending.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    30 daysminimum retail transition supply
    31 daysminimum LTC transition supply

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    90 days
    transition period
    3 daysmember notice timeframe

    Coverage Criteria — Transition Supplies

    Retail Transition

    Retail transition — covered when ALL of the following are met

    Retail Transition Criteria: Member is a new enrollee or a current member affected by a formulary change within the first 90 days of eligibility or the first 90 days of a new contract year; prescribed medication is a Part D drug that is non-formulary or subject to prior authorization or step therapy; prescription is for a short-term supply (Plan provides at least 30 days unless the prescription is written for less than 30 days).30 days minimum retail supply

    Applies to retail setting.

    Long-Term Care Transition

    Long-term care (LTC) transition — covered when ALL of the following are met

    LTC Transition Criteria: Member is a new enrollee or a current long-term care resident affected by a formulary change within the first 90 days of eligibility or the first 90 days of a new contract year; prescribed medication is a Part D drug that is non-formulary or subject to prior authorization or step therapy; Plan will provide at least a 31-day supply (unless the prescription is written for less than 31 days) and will honor multiple fills as needed to meet the 31-day supply; Plan will provide an emergency supply outside the 90-day period while an exception is pending for LTC residents.31 days minimum LTC supply

    Applies to long-term care setting; multiple fills allowed to meet 31-day supply; emergency supply available while exception is processed.

    Transition Extension

    Transition extension — covered when ALL of the following are met

    Transition Extension: An exception request or appeal remains unprocessed at the end of the minimum transition period; member or representative requests an extension by calling Aspirus Health Plan Medicare Advantage Plans Customer Service; extension is granted on a case-by-case basis; the extended transition ends when the medication is changed to a formulary alternative or the exception/appeal is decided.case-by-case

    Member or representative must call Customer Service to request extension.

    Some medications do not qualify for temporary transition coverage because they are excluded from Medicare prescription drug benefits or require a separate Part B vs Part D coverage determination. Examples include weight loss drugs, cosmetic drugs, over-the-counter (OTC) drugs, medications that need a Part B versus Part D determination, and Medicare-covered drugs prescribed for a non‑approved indication. These products may be denied transition supplies and providers should verify coverage pathway before dispensing.

    Provider Actions, Notices, and Operational Steps

    Step Therapy

    Temporary coverage during prior authorization/step therapy

    Aspirus Arise provides temporary coverage for Part D drugs when members cannot immediately access their regular medications. This temporary supply applies to drugs that are on the formulary but require prior authorization or step therapy, and to non‑formulary Part D drugs in eligible transition situations. The temporary coverage is limited and intended to allow time for prior authorization, step‑therapy completion, or formulary/coverage resolution.

    • Retail transition: at least a 30‑day temporary supply for new members or members affected by new formulary restrictions within the first 90 days of eligibility; includes formulary drugs requiring prior authorization or step therapy.
    • LTC transition: at least a 31‑day temporary supply for new LTC residents or LTC members affected by new formulary restrictions within the first 90 days of eligibility; includes formulary drugs requiring prior authorization or step therapy.
    • LTC emergency supply: multiple fills may be authorized as needed up to 31 days while an exception is processed or during transition period.
    • Temporary coverage does not remove the requirement for prior authorization/step therapy; it simply provides a short supply while those processes are completed.
    Step Therapy

    Definitions and Key Terms

    Transition period — definitions
    DefinitionThe transition period is the first 90 days of eligibility for new members or the first 90 days of a new contract year for current members affected by formulary changes.
    Retail minimum supplyAspirus will provide a temporary supply of non‑formulary Part D drugs for at least 30 days (unless prescription is written for less).
    Long‑term care (LTC) minimum supplyAspirus will provide a temporary supply of non‑formulary Part D drugs for at least 31 days (unless prescription is written for less).
    LTC multiple fillsIn a long‑term care setting, Aspirus will honor multiple fills as needed to meet the 31‑day supply.
    Includes prior auth/step therapyTransition supplies include Part D drugs on the formulary that require prior authorization or step therapy.

    Background and Scope

    This policy ensures continuity of therapy by providing short-term supplies of Part D medications when members experience coverage disruptions due to enrollment changes, formulary changes, level-of-care transfers, or pending coverage determinations. It applies to members in both retail and long-term care settings and is intended to bridge therapy while prior authorizations, step therapy requirements, formulary exceptions, or appeals are processed.

    Policy Summary
    PayerAspirus Arise
    PolicyPart D Prescription Drug Transition Policy
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionProvide a temporary supply (retail 30 days; LTC 31 days) while prior authorization, step therapy, or exception is pending.
    SourceLink
    On This Page
    Coverage Criteria — Transition SuppliesProvider Actions, Notices, and Operational StepsDefinitions and Key TermsBackground and Scope

    Temporary coverage during step therapy

    When a step‑therapy requirement applies, Aspirus Arise will provide a temporary supply so the member is not left without medication while meeting the step‑therapy requirements. Retail and long‑term care settings have distinct temporary supply rules.

    • Retail: at least a 30‑day temporary supply for members in transition; includes drugs on the formulary that require step therapy.
    • Long‑term care: at least a 31‑day temporary supply and the plan may honor multiple fills as needed up to a 31‑day supply while step‑therapy requirements are addressed.
    • If the prescription is written for less than the minimum transition supply, the plan will provide the quantity written.
    Denial Risk

    Drugs excluded from Medicare coverage or requiring Part B vs Part D review

    Some drugs are not eligible for the Part D transition process because they are excluded from Medicare Part D coverage or require a Part B vs Part D determination. Providers should verify coverage eligibility before relying on transition supplies.

    • Examples of exclusions: weight‑loss drugs, cosmetic drugs, over‑the‑counter (OTC) drugs, and other drugs excluded from Medicare coverage.
    • Drugs requiring Part B vs Part D determination or Medicare‑covered drugs prescribed for a non‑approved indication may not qualify for transition.
    • If a drug is excluded from Part D or requires a Part B determination, standard transition supplies will not be provided; submit a coverage determination request if appropriate.
    Note

    Member notice and information

    Aspirus Arise will send written notice to members within three business days of the transition fill explaining that the supply is temporary and providing instructions on next steps.

    • Notice will include how to work with the prescriber to find an alternative medication, how to request a formulary exception, and the cost‑sharing amount for the one‑time transition based on drug tier and Extra Help status.
    • Members may call customer service (number on member ID card) or TTY 1.855.931.4852 for assistance; customer service hours 8 am–8 pm, seven days a week.